Cortechs.ai | Automatic brain segmentation for all: the power of the Dynamic Atlas™

Automatic brain segmentation for all: the power of the Dynamic Atlas™

In 1996 FreeSurfer§, and later NeuroQuant® in 2006, revolutionized image segmentation by introducing software for the automation of processing and analyzing MRIs. The Bayesian approach used for this automatic image segmentation was based on a static atlas, which works very well for a large part of the population but shows limitations when the subject’s anatomy is too far from the generic norm or too far outside the standard cohort age range.

One June 1, 2015, Cortechs.ai released the patented Dynamic Atlas™ developed for NeuroQuant 2.0, which introduces a new unique, approach allowing automatic segmentation and volume measurements for patients ranging from 3-100 years, and furthering robustness of segmentation and goodness-of-fit across all age ranges to atlas.

Cortechs.ai | Automatic brain segmentation for all: the power of the Dynamic Atlas™

The Dynamic Atlas creates a personalized atlas instantaneously based on patient specific covariates and prior anatomical knowledge derived from a large database. The prior knowledge is represented by the target image, likelihoods, and class priors, which are compiled over a large cohort of individuals.

Using proprietary algorithms, the patients observed data, which is comprised of original image data and derived data from image registration and segmentation, is further processed to predict the atlas parameters for an individual. An individual’s atlas parameters then form the basis of the personalized atlas allowing for the segmentation of virtually any patient instantly.

Want to learn more about Cortechs.ai Dynamic Atlas? Cortechs.ai has developed a Dynamic Atlas white paper, which is now available for download.

 

[§] The FreeSurfer software application for cortical reconstruction and volumetric segmentation was originally developed by Anders M. Dale et al. at Massachusetts General Hospital/Harvard Medical School and is jointly owned by Cortechs.ai and Massachusetts General Hospital.

More Resources

09/02/2025

Maximizing the Value of Prostate MRI for the Urologist

Even with expert radiologists or AI models at hand, the challenge remains: how can urologists improve seeing and interpreting cancer?

08/18/2025

Why Bigger Normative Databases Mean Better Brain Imaging

NeuroQuant® 5.2 compares patient brain MRI volumes to over 7,000 healthy scans, giving clinicians clear, percentile-based context for better assessments.

08/07/2025

Navigating Reimbursement for NeuroQuant: Understanding CPT Codes 0865T & 0866T 

Let’s break down the latest category III CPT codes and example clinical use cases that illustrate their value.

07/31/2025

Precision Without the Pressure: Smarter Brain Tumor Monitoring

Learn about NeuroQuant Brain Tumor 2.0 and how it assists clinicians by providing objective quantification and analysis of tumor changes over time.

07/30/2025

Cortechs.ai Announce Next-Gen NeuroQuant Brain Tumor: AI-Driven Metastasis & Meningioma Segmentation 

NeuroQuant Brain Tumor is the first FDA-cleared, cloud-native tool to offer automated volumetric segmentation for brain metastases, meningiomas, and gliomas.

07/28/2025

Longitudinal Assessment of Traumatic Brain Injury Using NeuroQuant®

A case study with Dr. Suzie Bash on NeuroQuant as a reliable, reimbursable, and efficient tool in the evaluation and follow-up of TBI.
Scroll to Top